Aspen Pharmacare, a leading multinational pharmaceutical company, has secured a €500 million (R9.9 billion) loan package from a development finance consortium led by the World Bank’s International Finance Corporation (IFC). This substantial funding will further enhance Aspen’s efforts to develop and manufacture medicines and vaccines for the African continent. This new financing follows a €600 million long-term debt package Aspen…